Clinical Trials

Inclusion Criteria:

- Age > 18 years

- Patient has undergone office-based evaluation for hematuria (computed tomography [CT],
ultrasound, cystoscopy)

Exclusion Criteria:

- Patient has known cancer outside of the target cancer 5 years prior to current
collection (not including basal cell or squamous cell skin cancers; if patient has not
been seen or if information is not available, the patient is eligible)

- Patient has recurrent muscle invasive bladder cancer

- Patient has ever been previously diagnosed with UTUC (upper tract urothelial
carcinoma) prior to bladder resection

- Patient has received chemotherapy class drugs for the treatment of non-target origin
cancer in the 5 years prior to current collection

- Patient has had any prior radiation therapy to the target lesion prior to current
collection

- Patient has had a biopsy to the target organ and/or lesion within 3 days before
collection

- Patient has undergone cystectomy

- Patient has transurethral instrumentation (placement of urinary catheter) within 7
days prior to urine collection

- Patient has had a urinary tract infection within 14 days prior to urine collection

- Patient has chronic indwelling urinary catheter

- Patient has prior diagnosis of bladder cancer for which prior resection of tumor was
performed

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 4/10/2024. Questions regarding updates should be directed to the study team contact.